{
    "eid": "2-s2.0-85136694847",
    "title": "Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Cancer patients",
        "Cancer treatments",
        "ChAdOx1-nCoV-19 vaccine",
        "Immunogenicity"
    ],
    "authors": [
        "Nattaya Teeyapun",
        "Sutima Luangdilok",
        "Nussara Pakvisal",
        "Panot Sainamthip",
        "Siyamol Mingmalairak",
        "Nattaya Poovorawan",
        "Piyada Sitthideatphaiboon",
        "Napa Parinyanitikul",
        "Virote Sriuranpong",
        "Teerayuth Namkanisorn",
        "Pratchaya Inthasuwan",
        "Pattama Angspatt",
        "Ploytuangporn Wongchanapat",
        "Akradach Bamrungnam",
        "Nutchanok Leeleakpai",
        "Sutheera Uttha",
        "Supaporn Jaichum",
        "Peerawich Kongkaew",
        "Chayanin Suksanong",
        "Rattiya Veranitinun",
        "Ampai Prasomphol",
        "Chada Sartsuk",
        "Cheeraporn Patcharajutanon",
        "Supreeya Preaprang",
        "Hathairat Choengsamor",
        "Rungthong Phongwan",
        "Charoenpit Preeyasaksa",
        "Ekkamol Phaibulvatanapong",
        "Nungruthai Suntronwong",
        "Ritthideach Yorsaeng",
        "Preeyaporn Vichaiwattana",
        "Nasamon Wanlapakorn",
        "Stephen J. Kerr",
        "Yong Poovorawan",
        "Passakorn Wanchaijiraboon",
        "Suebpong Tanasanvimon"
    ],
    "citedby-count": 5,
    "ref-count": 25,
    "ref-list": [
        "Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data",
        "Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited",
        "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer",
        "High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers",
        "mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial",
        "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine",
        "SARS-CoV-2 vaccines",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine",
        "Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study",
        "Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer",
        "Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer",
        "Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study",
        "Seroconversion rates following COVID-19 vaccination among patients with cancer",
        "Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients",
        "Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors",
        "Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors",
        "Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chantaburi",
            "@id": "128297194",
            "affilname": "Phrapokklao Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128297194",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Samutprakarn",
            "@id": "125776680",
            "affilname": "Samutprakarn Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125776680",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Institutes of Health and Foundation for AIDS Research"
    ]
}